Facilitating Electrical Cardioversion of Persistant Atrial Fibrillation by Antiarrhythmic Drugs: Update on Clinical Trial Results

Author： Sung R.J.  

Publisher： Springer Publishing Company

ISSN： 1385-2264

Source： Cardiac Electrophysiology Review, Vol.7, Iss.3, 2003-09, pp. : 300-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Update on Electrical Cardioversion of Atrial Fibrillation

By Mittal S.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 3, 2003-09 ,pp. : 285-289

Springer Publishing Company

Access to resources Recommend Favorite

Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation: ACUTE Trial Update

By Asher C.R.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 4, 2003-12 ,pp. : 387-391

Springer Publishing Company

Access to resources Recommend Favorite

Atorvastatin Given prior to Electrical Cardioversion Does Not Affect the Recurrence of Atrial Fibrillation in Patients with Persistent Atrial Fibrillation Who Are on Antiarrhythmic Therapy

By  

Medical Principles and Practice, Vol. 20, Iss. 5, 2011-07 ,pp. : 464-469

Karger

Access to resources Recommend Favorite

Azimilide for Atrial Fibrillation: Clinical Trial Results and Implications

By Pritchett E.L.C.  

Cardiac Electrophysiology Review, Vol. 7, Iss. 3, 2003-09 ,pp. : 215-219

Springer Publishing Company

Access to resources Recommend Favorite

Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management

By  

Current Vascular Pharmacology, Vol. 5, Iss. 3, 2007-07 ,pp. : 185-194

Bentham Science Publishers

Access to resources Recommend Favorite